NCT01428830

Brief Summary

This facility-based, multi-center randomized controlled trial (RCT) will test the non-inferiority of short-term (7 day) urethral catheterization compared to longer-term (14 day) urethral catheterization in terms of predicting fistula repair breakdown three months following urinary fistula repair surgery. The study will be conducted among 507 women with simple fistula presenting at 8 study sites in Sub-Saharan Africa for fistula repair surgery.

Trial Health

93
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
524

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2012

Geographic Reach
8 countries

8 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 2, 2011

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 5, 2011

Completed
4 months until next milestone

Study Start

First participant enrolled

January 1, 2012

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2013

Completed
Last Updated

January 19, 2015

Status Verified

January 1, 2015

Enrollment Period

1.6 years

First QC Date

September 2, 2011

Last Update Submit

January 15, 2015

Conditions

Keywords

fistulacathetersurgeryobstetricsgynecologyurology

Outcome Measures

Primary Outcomes (1)

  • Fistula repair breakdown three months following fistula repair surgery as assessed by a urinary dye test.

    3 months

Secondary Outcomes (6)

  • Repair breakdown one week following catheter removal

    14 days or 21 days post-repair

  • Intermittent catheterization due to urinary retention

    7 or 14 days post repair

  • Prolonged hospitalization

    14 or 21 days post-repair

  • Catheter blockage

    14 or 21 days post repair

  • Self-reported residual incontinence

    3 months

  • +1 more secondary outcomes

Study Arms (2)

7-day catheterization

EXPERIMENTAL
Procedure: 7-day catheterization following fistula repair surgery

14-day catheterization

ACTIVE COMPARATOR
Procedure: 14 day catheterization

Interventions

This group will have an indwelling urethral catheter for 7 days following fistula repair surgery.

7-day catheterization

This group will have an indwelling urethral catheter for 14 days following fistula repair surgery.

14-day catheterization

Eligibility Criteria

Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may not qualify if:

  • Have a closed fistula at completion of surgery
  • Have a closed fistula 7 days after surgery (i.e. at the time of randomization)
  • Understand study procedures and requirements
  • Agree to return to the facility for one follow-up visit three month after the date of surgery
  • Provide informed consent to participate in the study or in the case of non-emancipated minors, both consent to the study and receive proxy consent to participate in the study
  • Have no contraindications precluding their participation.
  • Have a fistula that is determined to be "not simple" (i.e. intermediate or complex)
  • Have a fistula that is radiation-induced, associated with cancer or due to lymphogranuloma venereum (These cases will be excluded because the healing process is very different from fistula resulting from other causes. We expect there to be few cases of these fistulas at the study sites)
  • Have a fistula that is not closed immediately after surgery or 7 days after surgery (i.e. at the time of randomization)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (8)

Hôpital Saint Joseph

Kinshasa, Democratic Republic of the Congo

Location

Gondar University Hospital

Gonder, Ethiopia

Location

L'Hôpital Préfectoral de Kissidougou

Kissidougou, Guinea

Location

Kenyatta National Hospital

Nairobi, Kenya

Location

National Obstetric Fistula Centre

Abakaliki, Nigeria

Location

Maternité Centrale de Zinder

Zinder, Niger

Location

Aberdeen Women's Centre

Freetown, Sierra Leone

Location

Kagando Hospital

Kasese District, Uganda

Location

Related Publications (2)

  • Barone MA, Widmer M, Arrowsmith S, Ruminjo J, Seuc A, Landry E, Barry TH, Danladi D, Djangnikpo L, Gbawuru-Mansaray T, Harou I, Lewis A, Muleta M, Nembunzu D, Olupot R, Sunday-Adeoye I, Wakasiaka WK, Landoulsi S, Delamou A, Were L, Frajzyngier V, Beattie K, Gulmezoglu AM. Breakdown of simple female genital fistula repair after 7 day versus 14 day postoperative bladder catheterisation: a randomised, controlled, open-label, non-inferiority trial. Lancet. 2015 Jul 4;386(9988):56-62. doi: 10.1016/S0140-6736(14)62337-0. Epub 2015 Apr 21.

  • Barone MA, Frajzyngier V, Arrowsmith S, Ruminjo J, Seuc A, Landry E, Beattie K, Barry TH, Lewis A, Muleta M, Nembunzu D, Olupot R, Sunday-Adeoye I, Wakasiaka WK, Widmer M, Gulmezoglu AM. Non-inferiority of short-term urethral catheterization following fistula repair surgery: study protocol for a randomized controlled trial. BMC Womens Health. 2012 Mar 20;12:5. doi: 10.1186/1472-6874-12-5.

MeSH Terms

Conditions

Vaginal FistulaFistula

Interventions

Catheterization

Condition Hierarchy (Ancestors)

Vaginal DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

TherapeuticsInvestigative Techniques

Study Officials

  • Mark A Barone, DVM, MS

    EngenderHealth

    PRINCIPAL INVESTIGATOR
  • Mariana Widmer

    World Health Organization

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 2, 2011

First Posted

September 5, 2011

Study Start

January 1, 2012

Primary Completion

August 1, 2013

Study Completion

August 1, 2013

Last Updated

January 19, 2015

Record last verified: 2015-01

Locations